Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also ...

Eli Lilly is already one of the most innovative companies in the pharmaceutical industry. Over the past five years, it has ...

Public Citizen filed a lawsuit against the Trump administration in the U.S. District Court for the District of Columbia ...

Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...

Rob Schneider's wife files for divorce after 14 years of marriage A secret FBI bust nabbed an alleged drug lord—and rocked ...

The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth ...

As part of the deal, Repertoire Immune Medicines will develop up to three drug candidates that target the drivers of certain autoimmune diseases.

Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global AI medical ...

Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.

President Trump said he plans to announce who he will nominate for Federal Reserve chair next week. “We’re going to be ...